On March 20, 2026, Novo Nordisk's patent on semaglutide expired in India, triggering one of the most significant transformations in the country's pharmaceutical history. Within weeks, more than 40 Indian…
🔬 How to Choose a Reliable Indian Generic Medicine Supplier: A Complete Buyer’s Guide India supplies approximately 20% of the world’s generic medicines by volume, exporting over USD 50 billion…
The United States imposed a sweeping 100% tariff on patented pharmaceutical imports on April 2, 2026, under Section 232 of the Trade Expansion Act. However, generic medicines — which make…
New Delhi, May 2026 — India now supplies nearly 20% of the world’s generic medicines, according to a comprehensive report from the Global Trade Research Initiative (GTRI). The report, released…